T1198C polymorphism of the angiotensinogen gene and antihypertensive response to angiotensin-converting enzyme inhibitors

Hypertension Research

Volumn 28, Issue 12, 2005, Pages 981-986

  Yu, Huimin ^b   Lin, Shuguang ^b   Liu, Guozhang ^a   Zhang, Yuqing ^a   Deng, Chunyu ^b   Ma, Wenjun ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Angiotensinogen; Genes; Hypertension; Treatment

Indexed keywords

ANGIOTENSINOGEN; BENAZEPRIL; CYTOSINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMIDAPRIL; PLACEBO; THYMINE;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CHINESE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; ESSENTIAL HYPERTENSION; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PREDICTION; RANDOMIZED CONTROLLED TRIAL; RESTRICTION MAPPING; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENTS; BENZAZEPINES; BLOOD PRESSURE; CHINA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; IMIDAZOLIDINES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 33644543446     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.28.981     Document Type: Article

References (33)

1. Matsubara M, Metoki H, Katsuya T, et al: T+31C polymorphism (M235T) of the angiotensinogen gene and home blood pressure in the Japanese general population: the Ohasama Study. Hypertens Res 2003; 26: 37-46.
2. Jin JJ, Nakura J, Wu Z, et al: Association of angiotensin II type 2 receptor gene variant with hypertension. Hypertens Res 2003; 26: 547-552.
3. Ono K, Mannami T, Baba S, Yasui N, Ogihara T, Iwai N: Lack of association between angiotensin H type 1 receptor gene polymorphism and hypertension in Japanese. Hypertens Res 2003; 26: 131-134.
4. Kikuya M, Sugimoto K, Katsuya T, et al: A/C1166 gene polymorphism of the angiotensin II type 1 receptor (AT1) and ambulatory blood pressure: the Ohasama Study. Hypertens Res 2003; 26: 141-145.
5. Matsubara M, Sato T, Nishimura T, et al: CYP11B2 polymorphisms and home blood pressure in a population-based cohort in Japanese: the Ohasama Study. Hypertens Res 2004; 27: 1-6.
6. Kurland L, Liljedahl U, Karlsson J, et al: Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Am J Hypertens 2004; 17: 8-13.
7. Kurland L, Melhus H, Karlsson J, et al: Aldosterone synthase (CYP11B2) -344 C/T is related to antihypertensive response. Am J Hypertens 2002; 15: 387-393.
8. Sasaki M, Oki T, Luchi A, et al: Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies. J Hypertens 1996; 14: 1403-1408.
9. Dudley C, Keavney B, Casadei B, Conway J, Bird R, Ratcliffe P: Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of the renin-angiotensin system genes. J Hypertens 1996; 14: 259-262.
10. Nakano Y, Oshima T, Watanabe M, Matsuura H, Kajiyama G, Kambe M: Angiotensin I-converting enzyme gene polymorphism and acute response to captopril in essential hypertension. Am J Hypertens 1997; 10: 1064-1068.
11. Ueda S, Meredith PA, Morton JJ, Connell JMC, Elliott L: ACE (I/D) genotype as a predictor of the magnitude and duration of the response an ACE inhibitor drug (enalaprilat) in humans. Criculation 1998; 98: 2148-2153.
12. Liljedahl U, Karlsson J, Melhus H, et al: A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response. Pharmacogenetics 2003; 13: 7-17.
13. Miller JA, Thai K, Scholey JW: Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II. Kidney Int 1999; 56: 2173-2180.
14. Katsuya T, Iwashima Y, Sugimoto K, et al: Effects of anti-hypertensive drugs and gene variants in the renin-angiotensin system. Hypertens Res 2001; 24: 463-467.
15. Nakamura Y, Tamaki S, Uchida Y, et al: Angiotensin converting enzyme genotype influences the response to the angiotensin II receptor antagonist losartan in patients with hypertension. Hypertens Res 2004; 27: 137-140.
16. Yu H, Zhang Y, Lu G: Relationship between the polymorphism of the angiotensin converting enzyme gene and the response to angiotensin converting enzyme inhibition in hypertensive patients. Hypertens Res 2003; 26: 881-886.
17. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-180.
18. Kunz R, Kreutz R, Beige J, Distler A, Sharma AM: Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997; 30: 1331-1337.
19. Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R: M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999; 17: 9-17.
20. Katsuya T, Ishikawa K, Sugimoto K, Rakugi H, Ogihara T: Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res 2003; 26: 521-525.
21. Poch E, Gonzalez D, Giner V, Bragulat E, Coca A, de la Sierra A: Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension 2001; 38: 1204-1209.
22. Rotimi C, Puras A, Cooper R, et al: Polymorphism of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension 1996; 27: 558-563.
23. Caufield M, Lavender P, Newell Price J, et al: Linkage of the AGT gene to human EH in African Caribbeans. J Clin Invest 1995; 96: 687-692.
24. Imidapril and Benazepril Clinical Study Cooperation Unit: Comparative Study of Hypotensive Efficacy and the Cough Occurrence of Imidapril versus Benazepril. Chin J Cardiol 2004; 32: 304-307.
25. Mondorf UF, Russ A, Wiesemann A, Herrero M, Oremek G, Lenz T: Contribution of ACE gene polymorphism and angiotensinogen gene polymorphism to blood pressure reduction in essential hypertension. Am J Hypertens 1998; 11: 174-183.
26. Walker WG, Welton PK, Saito H, Rusell RP, Hermann J: Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979; 1: 287-291.
27. Hegele RA, Brunt JH, Connelly PW: A polymorphism of the angiotensin gene associated with variation in blood pressure in a genetic isolate. Circulation 1994; 90: 2207-2212.
28. Sethi AA, Nordestgaard BG, Tybjærg-Hansen A: Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol 2003; 23: 1269-1275.
29. Hingorani AD, Jia H, Stevens PA, Hopper R, Dickerson JE, Brown MJ: Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 1995; 13: 1602-1609.
30. Takahashi N, Hagaman JR, Kim HS, Smithies O: Computer simulations of blood pressure regulation by the renin-angiotensin system. Endocrinology 2003; 144: 2184-2190 (Minireview).
31. Juillerat L, Nussberger J, Menard J, et al: Determinants of angiotensin II generation during ACE inhibition. Hypertension 1990; 16: 564-572.
32. Caulfield M, Lavender P, Farrall M, et al: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994, 330: 1629-1633.
33. Martin ER, Lai EH, Gilbert JR, et al: SNPing away at complex disease: analysis of singe-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet 2000; 67: 383-394.